Conventional wisdom can be a reassuring thing. But sometimes it can be flat-out wrong. Consider 94-year-old Olga Kotelko.
Spare us the false hope about Alzheimer’s
By
John O'Connor
Nov 01, 2013
Here we go again: This week saw the release of yet another breathless study claiming the cure for Alzheimer’s disease is getting closer — maybe.
Governors eye block grants as way to cut Medicaid costs
By
John O'Connor
Jul 01, 2011
House Republicans would like to see Medicaid outlays trimmed dramatically. And they are hardly alone.
Big wound treatment in a small package
By
John O'Connor
Mar 01, 2011
An inexpensive nanometer-sized drug that can treat foot ulcers and other chronic wounds has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others...
Bone marrow cells key to wound healing
By
John O'Connor
May 02, 2011
Researchers at King’s College London and Osaka University in Japan have identified the chemical that summons stem cells from bone marrow to wound sites. The discovery could lead to new leg ulcer...
Residents who do these two things most likely to live 100 years
By
John O'Connor
Jun 23, 2020
Older adults who are socially engaged and don’t smoke dramatically improve their chances of living to age 100, researchers in New Zealand have found.
Feeling a bit run down? Blame the third shift
By
John O'Connor
Jan 31, 2014
Long-term care professionals must be on hand to work the dreaded third shift, given the 24/7 nature of the job. For some caregivers, that means extra difficulties getting through an overnight shift. New...
New stem cell population may hold key to skin tissue repairs
By
John O'Connor
Nov 01, 2012
Researchers have identified a new stem cell population in the skin epidermis that is responsible for tissue repair. The finding could lead to new wound care treatments, they say.
Omnicare extends PharMerica buy offer
By
John O'Connor
Jan 03, 2012
Pharmacy giant Omnicare announced that it was extending to Jan. 20 its offer to purchase all outstanding shares of rival PharMerica for $15 per share. The original offer had been scheduled to expire in...
For long-term operators, a growing list of ‘frenemies’
By
John O'Connor
Oct 06, 2014
Most of us are all too aware of our professional friends and enemies. But not so much when it comes to our “frenemies.” Given the many changes taking place in healthcare today, the frenemy...